In-depth research needed, only time will tell: V K Paul on mixing vaccines

According to a study conducted by the Spanish university, a combination of AstraZeneca and Pfizer vaccine was entirely safe and effective in controlling the spread and prevention of the disease

Topics
Coronavirus | Coronavirus Tests | Coronavirus Vaccine

ANI 

V K Paul
Photo: ANI

Taking two jabs of two different Covid vaccines is "theoretically possible", but more in-depth research is needed in the matter, Dr VK Paul, Member Health NITI aayog said on Saturday.

Addressing a press conference here today, Paul said, "You asked me if a person can get inoculated with a vaccine different from the one he received in the first dose. Scientifically & theoretically's possible. But recommending this, is an evolving situation. No robust scientific evidence. Only time will tell."

According to a study conducted by the Spanish university, a combination of AstraZeneca and Pfizer vaccine was entirely safe and effective in controlling the spread and prevention of the disease.

The study conducted by the Carlos III Health Institute in Spain found that the first dose of AstraZeneca followed by the second dose of Pfizer was absolutely safe and effective.

The university has backed its findings with the result of a clinical trial in which 673 participants aged below 60 years participated.

According to the Union Health Ministry, as many as 19,33,72,819 doses of COVID-19 vaccines have been administered so far since the commencement of the vaccination drive on January 16.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus
First Published: Sat, May 22 2021. 20:41 IST
RECOMMENDED FOR YOU